These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 15548809

  • 1. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL, Chatterjee S, Caine GJ, Hope-Ross M, Gibson J, Blann AD, Lip GY.
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [Abstract] [Full Text] [Related]

  • 2. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK, Blann A, Beevers DG, Lip GY.
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [Abstract] [Full Text] [Related]

  • 3. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment.
    Mohan JS, Lip PL, Blann AD, Bareford D, Lip GY.
    Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157
    [Abstract] [Full Text] [Related]

  • 4. Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure.
    Chong AY, Caine GJ, Freestone B, Blann AD, Lip GY.
    J Am Coll Cardiol; 2004 Feb 04; 43(3):423-8. PubMed ID: 15013125
    [Abstract] [Full Text] [Related]

  • 5. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes.
    Lee KW, Lip GY, Blann AD.
    Circulation; 2004 Oct 19; 110(16):2355-60. PubMed ID: 15302795
    [Abstract] [Full Text] [Related]

  • 6. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY.
    Invest Ophthalmol Vis Sci; 2000 Jul 19; 41(8):2115-9. PubMed ID: 10892852
    [Abstract] [Full Text] [Related]

  • 7. Plasma markers of angiogenesis in pregnancy induced hypertension.
    Nadar SK, Karalis I, Al Yemeni E, Blann AD, Lip GY.
    Thromb Haemost; 2005 Nov 19; 94(5):1071-6. PubMed ID: 16363251
    [Abstract] [Full Text] [Related]

  • 8. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer.
    Caine GJ, Stonelake PS, Lip GY, Blann AD.
    Cancer Lett; 2007 Apr 08; 248(1):131-6. PubMed ID: 16891056
    [Abstract] [Full Text] [Related]

  • 9. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, Murakami T, Kimura T, Takagi H.
    Am J Ophthalmol; 2005 Mar 08; 139(3):476-81. PubMed ID: 15767056
    [Abstract] [Full Text] [Related]

  • 10. Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease.
    Koutroubakis IE, Xidakis C, Karmiris K, Sfiridaki A, Kandidaki E, Kouroumalis EA.
    Eur J Clin Invest; 2006 Feb 08; 36(2):127-32. PubMed ID: 16436095
    [Abstract] [Full Text] [Related]

  • 11. Angiopoietic factors and retinopathy in pregnancies complicated with Type 1 diabetes.
    Loukovaara S, Immonen I, Koistinen R, Rudge J, Teramo KA, Laatikainen L, Hiilesmaa V, Kaaja RJ.
    Diabet Med; 2004 Jul 08; 21(7):697-704. PubMed ID: 15209761
    [Abstract] [Full Text] [Related]

  • 12. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H, Shi CH.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 30; 87(40):2837-9. PubMed ID: 18167288
    [Abstract] [Full Text] [Related]

  • 13. Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy.
    Nadar SK, Blann AD, Lip GY.
    J Intern Med; 2004 Oct 30; 256(4):331-7. PubMed ID: 15367176
    [Abstract] [Full Text] [Related]

  • 14. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H.
    Ophthalmology; 2008 Nov 30; 115(11):1916-22. PubMed ID: 18718666
    [Abstract] [Full Text] [Related]

  • 15. Effects of laser photocoagulation on serum angiopoietin-1, angiopoietin-2, angiopoietin-1/angiopoietin-2 ratio, and soluble angiopoietin receptor Tie-2 levels in type 2 diabetic patients with proliferative diabetic retinopathy.
    You QY, Zhuge FY, Zhu QQ, Si XW.
    Int J Ophthalmol; 2014 Nov 30; 7(4):648-53. PubMed ID: 25161936
    [Abstract] [Full Text] [Related]

  • 16. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.
    Peters S, Cree IA, Alexander R, Turowski P, Ockrim Z, Patel J, Boyd SR, Joussen AM, Ziemssen F, Hykin PG, Moss SE.
    Cytokine; 2007 Nov 30; 40(2):144-50. PubMed ID: 17959386
    [Abstract] [Full Text] [Related]

  • 17. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors.
    Serefhanoglu S, Goker H, Buyukasik Y, Turgut M, Sayinalp N, Haznedaroglu IC, Aksu S, Akman U, Ozcebe OI.
    Ann Hematol; 2009 Jul 30; 88(7):667-71. PubMed ID: 19082594
    [Abstract] [Full Text] [Related]

  • 18. Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers.
    Niedźwiecki S, Stepień T, Kopeć K, Kuzdak K, Komorowski J, Krupiński R, Stepień H.
    Cytokine; 2006 Dec 30; 36(5-6):291-5. PubMed ID: 17374490
    [Abstract] [Full Text] [Related]

  • 19. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.
    Lee CY, Tien HF, Hu CY, Chou WC, Lin LI.
    Br J Cancer; 2007 Oct 08; 97(7):877-82. PubMed ID: 17848952
    [Abstract] [Full Text] [Related]

  • 20. Risk evaluation of outcome of vitreous surgery for proliferative diabetic retinopathy based on vitreous level of vascular endothelial growth factor and angiotensin II.
    Funatsu H, Yamashita H, Noma H, Mimura T, Sakata K, Hori S.
    Br J Ophthalmol; 2004 Aug 08; 88(8):1064-8. PubMed ID: 15258026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.